Hallazgos clínicos, epidemiológicos, histológicos y anatómicos en pacientes adultos con diagnóstico de cáncer de páncreas / Clinical, Epidemiological, Histological and Anatomical Findings in Adult Patients Diagnosed with Pancreatic Cancer

Introducción: El cáncer de páncreas constituye un problema de salud debido al diagnóstico tardío, su agresividad biológica y la ausencia de un tratamiento sistémico efectivo. Objetivo: Caracterizar clínica, epidemiológica, histológica y anatómicamente a pacientes con cáncer de páncreas. Métodos: Se realizó un estudio descriptivo de casos clínicos, en pacientes con cáncer de páncreas que acudieron al Hospital Oncológico Conrado Benítez; de Santiago de Cuba, en el período comprendido diciembre 2017 hasta diciembre 2018. El universo estuvo conformado por el total de los pacientes de ambos sexos, cuya cifra ascendió a 19 que cumplieron con los criterios de inclusión. Resultados: No existió predominio significativo según el sexo, prevaleció el grupo de edades entre 61-70 años en un 31,6 por ciento, el 84,2 por ciento de los pacientes presentó como factor de riesgo la dieta rica en grasas y pobre en verduras y el tabaquismo, en el 63,2 por ciento coexistió la hipertensión arterial, la pérdida de peso fue el signo que sobresalió en el 79,0 por ciento. El 47,4 por ciento se les diagnosticó adenocarcinoma poco diferenciado, siendo la localización más frecuente de los tumores (31,6 por ciento) la cabeza del páncreas. Conclusiones: El cáncer de páncreas es una enfermedad maligna que se relacionada con la edad y sus síntomas se manifiestan tardíamente, se asocia con la presencia de factores de riesgo por lo que es necesario identificarlos precozmente, modificarlos y/o atenuarlos(AU)

Introduction: Pancreatic cancer constitutes a health problem due to late diagnosis, its biological aggressiveness and the absence of effective systemic treatment. Objective: To clinically, epidemiologically, histologically and anatomically characterize patients with pancreatic cancer. Methods: A descriptive study of clinical cases was carried out in patients with pancreatic cancer who attended the Conrado Benítez; Oncological Hospital of Santiago de Cuba, in the period from December 2017 to December 2018. The universe was made up of the total number of patients of both genders, which amounted to 19 meeting the inclusion criteria. Results: There was no significant predominance according to gender, the age group between 61-70 years prevailed in 31.6 percent, 84.2 percent of patients presented as risk factor the diet rich in fat and poor in vegetables and smoking, in 63.2 percent coexisted arterial hypertension, weight loss was the sign that stood out in 79.0 percent. The 47.4 percent were diagnosed with poorly differentiated adenocarcinoma, being the pancreatic head the most frequent location of the tumors (31.6 percent). Conclusions: Pancreatic cancer is an age-related malignant disease and its symptoms manifest late that is associated with the presence of risk factors, so it is necessary to identify them early, modify and/or attenuate them(AU)

Epidemiologia do câncer de pâncreas na América Latina e no Brasil / Epidemiology of pancreatic cancer in Latin America and Brazil

Introdução: O câncer de pâncreas é um tumor de alta letalidade, é o décimo segundo tipo mais comum e a sétima causa de morte, em ambos os sexos, no mundo. Estima-se que o câncer de pâncreas terá um aumento contínuo de incidência e mortalidade nos próximos 20 anos e isso causará um enorme ônus econômico para as populações em todo o mundo. Para o monitoramento e vigilância epidemiológica em câncer, pode-se apoiar em dados secundários como no Sistema de Informação em Mortalidade e dos registros de câncer (de base populacional e hospitalares) e estimativas a partir destes dados; por essa razão, investigou-se a epidemiologia do câncer de pâncreas na América Latina e no Brasil. Métodos: A tese compreende três manuscritos: (i) tendências de incidência, mortalidade e anos de vida ajustados por incapacidade (DALYs), bem como a fração de mortes por câncer de pâncreas atribuíveis a fatores de risco comportamentais e metabólicos em países da América Latina e Caribe (LAC) entre 1990 e 2019 (Global Burden Disease, 2019); (ii) mortalidade por câncer de pâncreas no Brasil e unidades da federação entre 1979 e 2019, dados do Sistema de Informação em Mortalidade (SIM); (iii) comparabilidade, validade, completude e pontualidade para cinco tumores gastrointestinais, câncer de esôfago, estômago, colorretal, fígado e pâncreas, em Registros de Câncer de Base Populacional (RCBPs) brasileiros. Resultados: Observou-se um aumento na incidência, mortalidade e DALYs para o câncer de pâncreas em ambos os sexos na maioria dos países da América Latina e Caribe; as maiores taxas de incidência e mortalidade foram observadas no Uruguai e as menores no Haiti. Redução na fração de mortes atribuíveis ao tabagismo entre 1990 e 2019, para ambos os sexos nos países da LAC; entretanto, aumento dentre os fatores metabólicos. No Brasil, entre 1979 e 2019, foram notificados um total de 209.425 óbitos por câncer de pâncreas, com tendência de aumento de 1,5% ao ano em homens e 1,9% em mulheres. Houve tendência de aumento da mortalidade na maioria dos estados brasileiros, com maiores tendências nas regiões Norte e Nordeste, e correlação positiva entre o índice de desenvolvimento humano e a tendência de aumento da mortalidade por câncer de pâncreas. Dentre os dezesseis RCBPs brasileiros estudados, todos atenderam aos critérios de comparabilidade, porém metade apresentou índices abaixo do esperado para validade e completude para tumores de fígado e pâncreas. Para pontualidade, os dezesseis registros apresentaram mais de 48 meses de atraso na divulgação dos dados em relação ao ano calendário de 2023. Considerações finais: O câncer de pâncreas representa um desafio para a saúde pública nos países da América Latina e no Brasil, diante do desafio na redução da incidência e da mortalidade, assim como na vigilância epidemiológica em câncer através dos RCBPs brasileiros que necessitam de suporte para continuidade do monitoramento da incidência do câncer.

Introduction: Pancreatic cancer is a tumor of high lethality, is the twelfth most common type and the seventh cause of death, in both sexes, in the world. It is estimated that pancreatic cancer will have a continuous increase in incidence and mortality over the next 20 years and this will cause a huge economic burden for populations around the world. For epidemiological monitoring and surveillance in cancer, it is possible to use on secondary data such as the Mortality Information System and cancer registries (population-based and hospital) and estimates from these data, for this reason the epidemiology of pancreatic cancer in Latin America and Brazil was investigated. Methods: The thesis comprises three manuscripts: (i) trends in incidence, mortality and disability-adjusted life years (DALYs) as well as the fraction of pancreatic cancer deaths attributable to behavioral and metabolic risk factors in Latin American and Caribbean (LAC) countries between 1990 and 2019 (Global Burden Disease, GBD 2019); (ii) mortality from pancreatic cancer in Brazil and federal units between 1979 and 2019, data from the Mortality Information System (SIM); (iii) comparability, validity, completeness and timeless for five gastrointestinal tumors, esophageal, stomach, colorectal, liver and pancreatic cancers, in the Brazilian Population-Based Cancer Registries (PBCRs). Results: An increase in the incidence, mortality and DALYs of pancreatic cancer was observed in most countries in Latin America and the Caribbean, the highest incidence and mortality rates were observed in Uruguay and the lowest in Haiti. The fraction of pancreatic cancer deaths attributable to smoking reduced between 1990 and 2019 for both sexes in LAC countries, however, it increased for metabolic risk factors. In Brazil, between 1979 and 2019, a total of 209,425 deaths from pancreatic cancer were reported, with a trend of increase of 1.5% per year in men and 1.9% in women. There was an increase in mortality in most Brazilian states, higher in the North and Northeast regions with a positive correlation between the improvement of the human development index and the trend of increased mortality from pancreatic cancer. Among the sixteen Brazilian PBCRs studied, all agreement the criteria of comparability, but half have lower than expected indices for validity and completeness for liver and pancreatic tumors, and as for timeless the sixteen records are more than 48 months late in the release of data in relation to the calendar year 2023. Conclusions: Pancreatic cancer represents a challenge for public health in LAC and Brazil, given the challenge in reducing incidence and mortality, as well as in epidemiological surveillance in cancer through Brazilian PBCRs to ensure the activity and stability for continued monitoring of cancer incidence.

Caracterización clinicoepidemiológica de pacientes con cáncer de páncreas en un servicio de cirugía general / Clinical epidemiological characterization of patients with pancreas cancer in a general surgery service

Introducción: El cáncer de páncreas constituye una de las neoplasias de peor pronóstico debido a su diagnóstico tardío. Objetivo: Caracterizar a los pacientes con cáncer de páncreas según variables clinicoepidemiológicas y exámenes complementarios. Métodos: Se realizó un estudio observacional, descriptivo y transversal de 70 pacientes con cáncer de páncreas, egresados del Servicio de Cirugía General del Hospital Provincial Docente Saturnino Lora de Santiago de Cuba durante el periodo 2016-2020. Se estudiaron las variables: edad, sexo, factores de riesgo, enfermedades asociadas, manifestaciones clínicas y exámenes complementarios. Resultados: Predominaron el sexo masculino ( 54,2 %), las edades comprendidas de entre 51- 70 años, la ingestión de comidas grasas y los hábitos tabáquico y alcohólico como factores de riesgo; el alcoholismo crónico, la diabetes mellitus y la hipertensión arterial como enfermedades asociadas más comunes, así como el síndrome general, la ictericia y la coluria entre las manifestaciones clínicas más frecuentes. Por su parte, según los estudios imagenológicos, la mayoría de los afectados se diagnosticaron mediante tomografía computarizada y ecografía abdominal (94,3 y 70,0 %, respectivamente). Conclusiones: La tomografía computarizada multicorte es la técnica de imagen de elección recomendada por las guías de consenso internacional. Si bien el informe radiográfico es clave para la toma de decisiones posteriores, existen circunstancias del paciente que pueden afectarlas, tales como edad, factores de riesgo, manifestaciones clínicas y comorbilidad, entre otras.

Introduction: The pancreas cancer constitutes one of the neoplasms with worse prognosis due to its late diagnosis. Objective: To characterize patients with pancreas cancer according to clinical epidemiological variables and complementary exams. Methods: An observational, descriptive and cross-sectional study of 70 patients with pancreas cancer was carried out, who were discharged from the General Surgery Service of Saturnino Lora Teaching Provincial Hospital in Santiago de Cuba during 2016-2020. The variables studied were: age, sex, risk factors, associated diseases, signs and symptoms and complementary exams. Results: There was a prevalence of the male sex (54.2 %), the 51-70 age group, the ingestion of fatty foods and nicotine addiction and alcoholism as risk factors, the chronic alcoholism, diabetes mellitus and hypertension as more common associated diseases, as well as the general syndrome, jaundice and coluria among the most frequent signs and symptoms. On the other hand, according to the imaging studies, most of those affected were diagnosed by means of computerized axial tomography and abdominal echography (94.3 and 70.0 %, respectively). Conclusions: The multiscan computerized axial tomography is the image technique of election recommended by the guides of international consent. The radiographic report is the key for later decisions making but there are circumstances of the patient that can affect them, such as age, risk factors, signs and symptoms and comorbidity, among others.

Caracterización epidemiológica del cáncer de pancreas en Solca Guayaquil: período 2015-2021 / Epidemiological characterization of pancreatic cancer in Solca Guayaquil: period 2015-2021

Dentro de los cánceres, el tumor maligno de páncreas sigue siendo una neoplasia altamente letal y se tiene dificultad en el diagnóstico temprano, por lo que hay que evaluar de manera sistemática el comportamiento epidemiológico de esta enfermedad. OBJETIVO: determinar las características epidemiológicas del cáncer de páncreas de los pacientes atendidos en el hospital SOLCA Guayaquil, entre los años 2015 al 2021. MATERIALES Y MÉTODO: observacional, de diseño transversal, tipo descriptivo; en los pacientes vistos por primera vez con tumor maligno de páncreas atendidos en el hospital de SOLCA y que sean residentes de Guayaquil; excluyéndose los pacientes diagnosticados en otras instituciones. RESULTADOS: durante el período 2015-2021 el cáncer de páncreas se incrementó, del año 2015 con 4,8% al 2021 de 29,3%; es corroborado con la tendencia lineal con porcentaje de variabilidad del 81%; según sexo hubo un cambio en la presentación entre hombres y mujeres en la incidencia; más en mujeres con 56,9%. el grupo de edad mayormente afectado en ambos sexos fue de 50-70 años (76,6%); topográficamente el Tumor maligno de páncreas, parte no especificada fue del 49,7%, Tumor maligno de cabeza del páncreas con 27,5% y morfológicamente el adenocarcinoma SAI (31,7%) y adenocarcinoma del conducto SAI (11,4%). CONCLUSIÓN: el cáncer de páncreas viene incrementándose, con mayor proporción en mujeres entre 50-70 años de edad; topográficamente el Tumor maligno de páncreas, parte no especificada y morfológicamente el adenocarcinoma SAI fueron lo más frecuentes; por lo que se debe explorar métodos que permitan un diagnóstico temprano

Within cancers, malignant tumor of pancreas continues to be a lethal neoplasm and early diagnosis is difficult, for epidemiological behavior must be systematically evaluated. OBJECTIVE: determine the epidemiological characteristics of pancreatic cancer in patients treated at the SOLCA Guayaquil hospital, between 2015 and 2021. MATERIALS AND METHOD: observational, cross-sectional design, descriptive type; in patients seen for the first time with a malignant tumor of the pancreas treated at the SOLCA hospital and who are residents of Guayaquil; excluding patients diagnosed in other institutions. RESULTS: during the 2015-2021 period, pancreatic cancer increased, from 2015 with 4.8% to 2021 with 29.3%; it is corroborated with the linear trend with a percentage of variability of 81%; According to sex, there was a change in the presentation between men and women in the incidence; more in women with 56.9%. the most affected age group in both sexes was 50-70 years (76.6%); topographically, malignant tumor of the pancreas, part not specified was 49.7%, malignant tumor of the head of the pancreas with 27.5% and morphologically, adenocarcinoma SAI (31.7%) and duct adenocarcinoma SAI (11.4%). CONCLUSION: pancreatic cancer has been increasing, with a higher proportion in women between 50-70 years of age; topographically, malignant tumor of the pancreas, unspecified part and morphologically, adenocarcinoma SAI were the most frequent; Therefore, methods that allow an early diagnosis should be explored.

Análise da sobrevida de pacientes com câncer de pâncreas / Survival analysis of patients with pancreatic cancer

Objetivo: Estimar a taxa de sobrevida por câncer de pâncreas. Métodos: Trata-se de estudo com delineamento de coorte retrospectiva, realizado no período de 2007 a 2018, em um hospital terciário no Sul do Brasil. A amostra foi composta de 66 indivíduos que realizaram acompanhamento no Hospital Nossa Senhora da Conceição, em Tubarão (SC), cujo sítio primário da doença tenha sido o pâncreas. Resultados: Dos 66 prontuários avaliados, 35 pertenciam a pessoas do sexo masculino (53%), com média de idade de diagnóstico de 64,3 anos. O estádio mais prevalente foi o IV (46 pacientes, correspondente a 69,7%). O tempo médio de sobrevida global foi de 462,02 dias (desvio-padrão de 90,76), e a mediana foi de 320 dias. Conclusão: Identificou-se uma prevalência maior em pessoas do sexo masculino, idosos e caucasianos e em indivíduos no estadiamento IV.

Objective: To estimate the survival rate for pancreatic cancer. Methods: This is aretrospective cohort study conducted from 2007 to 2018 in a tertiary hospital in Southern Brazil. The sample consisted of 66 individuals followed up at Hospital Nossa Senhora da Conceição, in Tubarão (SC), whose primary site of the disease was the pancreas. Results: Of the 66 medical records assessed, 35 were of male (53%) individuals, with a mean age at diagnosis of 64.3 years. The most prevalent stage was IV (46 patients, corresponding to 69.7%). The mean overall survival time was 462.02 days (standard deviation of 90.76) and the median was 320 days. Conclusion: Higher prevalence of males, elderly people, and Caucasians was observed, as well as IV staging.

Perfil Clínico-Epidemiológico e Sobrevida Global em Pacientes com Adenocarcinoma de Pâncreas em um Hospital de Referência em Oncologia / Clinical Epidemiological Profile and Global Survival in Patients with Pancreatic Adenocarcinoma at a Reference Hospital in Oncology / Perfil Clínico-Epidemiológico y Supervivencia General en Pacientes com Adenocarcinoma de Páncreas em un Hospital de Referencia em Oncología

Introdução: A neoplasia maligna de pâncreas configura uma das neoplasias de maior mortalidade em todo o mundo, quase sempre atrelada a um prognóstico sombrio, principalmente quando associada à disseminação linfática e para órgãos distantes. Objetivo: Avaliar a sobrevida global em pacientes com adenocarcinoma de pâncreas atendidos em um centro especializado em oncologia. Método: No período de janeiro de 2011 a dezembro de 2014, foram avaliados retrospectivamente 71 prontuários. Os dados foram analisados pelo software STATA versão 14, utilizando análise de Kaplan-Meier e de regressão de Cox. O intervalo de confiança utilizado foi de 95% e considerado significante p<0,05. Foram preservados os princípios éticos e da confidencialidade. Resultados: Houve predomínio do sexo masculino, raça parda e com idade superior a 61 anos ao diagnóstico. Quanto às características clínicas, 87,8% dos tumores estavam localizados em cabeça de pâncreas. A dor abdominal (92,7%) foi o sintoma mais frequente, seguida de perda progressiva de peso (79,3%) e icterícia (57,3%). A taxa de sobrevida em três meses de acompanhamento foi de 48,4%. Conclusão: O estudo evidencia que o câncer de pâncreas tem uma repercussão extremamente negativa, visto que a maioria dos pacientes recebe o diagnóstico em estágios avançados da doença, dificultando a possibilidade de tratamento curativo.

Introduction: Pancreatic malignant neoplasia represents one of the highest mortality neoplasms worldwide, almost always associated to a dismal prognosis, especially when associated with lymphatic spread and to distant organs. Objective: To assess the global survival in patients with pancreatic adenocarcinoma treated at a specialized oncology center. Method: From January 2011 to December 2014, 71 medical records were retrospectively evaluated. The data were analyzed using the STATA software version 14, using the Kaplan-Meier curve and the Cox regression. The confidence interval used was 95% (p<0.05). Ethical and confidentiality principles have been secured. Results: There was predominance of males, mixed race and over 61 years of age at diagnosis. As for the clinical characteristics, 87.8% of the tumors were located in the head of the pancreas. Abdominal pain (92.7%) was the most frequent symptom, followed by progressive weight loss (79.3%) and jaundice (57.3%). The three-month follow-up survival rate was 48.4%. Conclusion: The study shows that pancreatic cancer has an extremely negative repercussion, since most patients are diagnosed in advanced stages of the disease, hindering the possibility of curative treatment.

Introducción: La neoplasia maligna pancreática representa una de las neoplasias de mortalidad más altas del mundo, casi siempre vinculada a un pronóstico sombrío, especialmente cuando se asocia con diseminación linfática y órganos distantes. Objetivo: Evaluar la supervivencia global en pacientes con adenocarcinoma pancreático tratados en un centro de oncología especializado. Método: Desde enero de 2011 hasta diciembre de 2014, se evaluaron retrospectivamente 71 registros médicos. Los datos se analizaron utilizando el software STATA versión 14, utilizando la curva de Kaplan-Meier y la regresión de Cox. El intervalo de confianza utilizado fue del 95% (p<0,05). Se han preservado los principios éticos y de confidencialidad. Resultados: Predominó el sexo masculino, la raza mixta y los mayores de 61 años en el momento del diagnóstico. En cuanto a las características clínicas, el 87,8% de los tumores se ubicaron en la cabeza del páncreas. El dolor abdominal (92,7%) fue el síntoma más frecuente, seguido de pérdida progresiva de peso (79,3%) e ictericia (57,3%). La tasa de supervivencia de seguimiento a los tres meses fue del 48,4%. Conclusión: El estudio muestra que el cáncer de páncreas tiene un impacto extremadamente negativo, ya que la mayoría de los pacientes reciben el diagnóstico en etapas avanzadas, obstaculizando la posibilidad de tratamiento curativo.

Is there a link between non-alcoholic fatty liver disease aspects and pancreatic cancer? Results of a case-matched study / Existe ligação entre a doença hepática gordurosa não alcoólica e o câncer de pâncreas? Resultados de estudo caso-controle

ABSTRACT Background and Aims: An association between non-alcoholic fatty liver disease (NAFLD) and pancreatic ductal adenocarcinoma (PDAC) has been previously suggested. This study aims at investigating this association and at identifying potential links between variables of the NAFLD spectrum and PDAC. Methods: A cross-sectional case-matched analytical and comparative study was carried out to analyze patients undergoing surgical resection of PDAC and compare them to a control group of individuals undergoing cholecystectomy at a public tertiary teaching hospital, matched by sex, age and BMI. Hepatic histopathological examinations were compared between cases and controls. Results: Of 56 individuals, 36 were male (64.3%) and the median age was 61.5 years old (interquartile range: 57.5 - 70). The participants' median BMI was 24.3 kg/m2 (interquartile range: 22.1-26.2 kg/m2). Microvesicular steatosis (p=0.04), hepatocellular ballooning (p=0.02), fibrosis (p=0.0003) and steatohepatitis (p=0.03) were significantly more frequent in the group of cases. Odds ratios for hepatocellular ballooning (6.2; 95%CI: 1.2-31.8; p=0.03), fibrosis (9.3; 95%CI: 2.5-34.1; p=0.0008) and steatohepatitis (3.9; 95%CI: 1.1-14.3; p=0.04) were statistically significant in relation to the PDAC prevalence. Conclusions: Significant associations were identified between histopathological aspects of NAFLD (microvesicular steatosis, hepatocellular ballooning, fibrosis, and steatohepatitis) and PDAC.

RESUMO Histórico e objetivos: a associação entre a doença hepática gordurosa não alcoólica (DHGNA) e o adenocarcinoma ductal pancreático (ACDP) foi sugerida anteriormente. Este estudo visa investigar esta associação e identificar possíveis ligações entre as variáveis do espectro da DHGNA e o ACDP. Métodos: foi realizado estudo transversal caso-controle analítico e comparativo para analisar pacientes submetidos a ressecção cirúrgica de ACDP e compará-los a grupo controle de indivíduos submetidos a colecistectomia em hospital público terciário de ensino, pareados por sexo, idade e IMC. Os exames histopatológicos hepáticos foram comparados entre casos e controles. Resultados: dos 56 indivíduos, 36 eram do sexo masculino (64,3%) e a idade mediana era de 61,5 anos de idade (intervalo interquartil 57,5-70). A mediana do IMC dos participantes foi de 24,3 kg/m2 (intervalo interquartil 22,1 26,2). Esteatose microvesicular (p = 0,04), balonização hepatocelular (p = 0,02), fibrose (p = 0,0003) e esteato-hepatite (p = 0,03) foram significativamente mais frequentes no grupo de casos. As razões de chances para balonização hepatocelular (6,2; IC 95%: 1,2 - 31,8; p = 0,03), fibrose (9,3; IC 95%: 2,5 - 34,1; p = 0,0008) e esteato-hepatite (3,9; IC 95%: 1,1 - 14,3; p = 0,04) foram estatisticamente significativas em relação à prevalência de ACDP. Conclusões: houve associações significativas entre aspectos histopatológicos de DHGNA (esteatose microvesicular, balonização hepatocelular, fibrose e esteato-hepatite) e a ocorrência de ACDP.

Does Prior Cancer Have an Influence on the Survival Outcomes of Patients with Localized Pancreatic Neuroendocrine Tumors? / 中国医学科学杂志(英文版)

Objective To investigate the impact of prior non-pancreatic cancer on the survival outcomes of patients with localized pancreatic neuroendocrine tumors (PanNETs). Methods We reviewed the Surveillance, Epidemiology, and End Results database and selected patients with localized PanNETs diagnosed between 1973 and 2015. We divided the patients into two groups according to the presence or absence of prior non-pancreatic malignancy. Before and after propensity score matching, we compared the clinicopathological characteristics and studied the overall survival and cancer-specific survival. Results A total of 357 (12.9%) of 2778 patients with localized PanNETs had prior cancer. A total of 1211 cases with only a localized PanNET and 133 cases with a localized PanNET and prior cancer had complete data and met the inclusion criteria of the current study. Patients with prior cancer were associated with advanced age (>65 years, 57.9% prior cancer

Características de la neoplasia quística mucinosa del páncreas en pacientes atendidos en un Hospital Nacional del Perú / Characteristics of pancreatic mucinous cystic neoplasm in patients treated at a National Hospital in Peru

RESUMEN Con el objetivo de analizar las características clínico, patológicas y quirúrgicas de la Neoplasia Quística Mucinosa de páncreas (NQM), se realizó un análisis de los pacientes del servicio de Cirugía de Páncreas, Bazo y Retroperitoneo del Hospital Nacional Guillermo Almenara Irigoyen en Lima, Perú desde enero del 2009 hasta octubre del 2018. La presencia del estroma ovárico se usó como criterio diagnóstico de NQM. De diez pacientes con edad promedio de 47,8 años, nueve fueron mujeres, las lesiones estuvieron localizadas en el páncreas distal, el tamaño tumoral promedio fue de 88,6 mm. En todos los pacientes se realizó una pancreatectomía distal siendo tres laparoscópicas, no hubo reoperaciones ni fallecidos, dos pacientes tuvieron carcinoma invasor asociado. En conclusión, la presentación de NQM es mayor en mujeres de edad media siendo la localización en el páncreas distal y el porcentaje de malignidad bajo. La cirugía laparoscópica es una alternativa de manejo.

ABSTRACT In order to analyze the clinical, pathological, and surgical characteristics of pancreatic mucinous cystic neoplasm (MCN), an analysis of the patients from the Pancreas, Spleen, and Retroperitoneal Surgery Service of the Guillermo Almenara Irigoyen National Hospital in Lima, Peru, was performed from January 2009 to October 2018. The presence of ovarian stroma was used as a diagnostic criterion for MCN. From ten patients with an average age of 47.8 years, nine were women; the lesions were located in the distal pancreas, and the average tumor size was 88.6 mm. All patients underwent a distal pancreatectomy, three of which were laparoscopic; there were no reoperations or deaths; two patients had associated invasive carcinoma. In conclusion, the frequency of MCN is higher in middle-aged women, being the location in the distal pancreas and the percentage of malignancy is low. Laparoscopic surgery is a disease management option.

Morbilidad y mortalidad en 1028 duodenopancreatectomías cefálicas / Morbidity and mortality afer 1028 cephalic duodenopancreatectomies

Antecedentes: en las últmas décadas se han extendido las indicaciones de duodenopancreatectomía cefálica (DPC). Sin embargo, las series con más de 1000 DPC provienen de unos pocos centros de los Estados Unidos y Europa y ninguna de Latinoamérica. Objetivo: evaluar la morbilidad y mortalidad de 1028 DPC consecutivas realizadas por un mismo equipo quirúrgico. Material y métodos: se analizaron los datos de una base prospectiva de 1028 DPC consecutivas. Se determinaron los datos demográficos, la indicación de la cirugía, el intervalo de tempo entre el inicio de los síntomas y la primera consulta, la clasificación de la American Society of Anesthesiologistis (ASA), el tipo de técnica quirúrgica, el tempo operatorio, la colocación de drenaje biliar previo, el diagnóstico anatomopatológico, la morbilidad y la mortalidad. Se compararon la morbilidad y la mortalidad de la DPC en dos centros de salud. Resultados: las 1028 DPC se realizaron en un período comprendido entre julio de 1994 y diciembre de 2014. La edad promedio fue 59,6 años y 565 pacientes (55%) fueron de sexo masculino. Las indicaciones más frecuentes fueron tumor de páncreas (n=262) y tumor de papila (n=249). En 670 casos se diagnosticó patología maligna. El promedio de tempo entre el inicio de los síntomas y la primera consulta fue de 71 días (rango 10 a 123 días). En 461 pacientes (44%) se drenó la vía biliar antes de la cirugía. En 399 pacientes (35,3%) se registraron una o varias complicaciones. La fistula pancreática (21%) y el vaciamiento gástrico retardado (11%) fueron las complicaciones más frecuentes. Se registró una mortalidad del 3,1% (32 pacientes). Todas las DPC fueron realizadas en dos centros, uno público (n=642) y el otro privado (n=386). Los pacientes operados en el centro público tuvieron en forma signi-ficativa mayor morbilidad (46% vs. 27%, p> 0,001) y mortalidad (4% vs. 1,5%, p< 0,001). Conclusión: la DPC realizada por cirujanos de alto volumen en cirugía pancreática tene elevada morbilidad, pero baja mortalidad. A pesar de los buenos resultados globales, la morbimortalidad de la DPC en un centro público fue significativamente mayor que la del centro privado.

Background: in recent decades the indicatons for pancreaticoduodenectomy (PD) has been extended. However, series of patentis with more than 1000 PD come from a few center in the USA and Europe and none from Latin America. Objective: to evaluate the morbidity and mortality of 1028 consecutive PD performed by the same surgical team. Material and methods: we analyzed data from a prospective data base of 1028 consecutive PD. The demographic data, the indicaton of surgery, the tme interval between the onset of symptoms and the frst consultaton, the classificaton of the ASA, the type of surgical technique, operative tme, placement of biliary drainage, the anatomopathological diagnosis, the morbidity and the mortality was determined. We compared the morbidity and mortality of the PD at two diferent health centers Resultis: the 1028 PD were performed in a period between July 1994 and December 2014. The mean age was 59.6 years and 565 (55%) were male. The most frequent indicatons were pancreatic tumor (n = 262) and ampullary tumor (n = 249). Malignant tumors were found in 670 patentis. The average tme between onset of symptoms and the frst consultaton was 71 days (range 10-123 days). Preoperative biliary drainage were performed in 461 (44%) patentis. Morbility was 35.3% (399 patentis). Pancreatic fistula (21%) and delayed gastric emptying (11%) were the most frequent complicatons. All PD were performed at two centers, one public (n = 642) and the other private (n = 386). Patentis operated at the private center had significantly lower morbidity (27% vs 46%, p <0.001) and mortality (1.5% vs 4%, p <0.001) Conclusion: the DPC performed by high-volume surgeons in pancreatic surgery has high morbility, but low mortality. Despite the overall good performance, morbidity and mortality of the DPC in a public center was significantly higher than the private center.

Tendência da mortalidade por câncer de pâncreas em Salvador - Brasil, 1980 a 2012 / Mortality trends from pancreatic cancer in Salvador - Brazil, 1980 to 2012 / Tendencia de mortalidad por cáncer de páncreas en Salvador - Brasil, 1980 y 2012

Introdução: O câncer de pâncreas apresenta taxas de letalidade que se aproximam de 100%, com cerca de 250 mil mortes anuais em todo mundo. Objetivo: Descrever a tendência da taxa de mortalidade por câncer de pâncreas no Estado da Bahia e na cidade de Salvador, de 1980 a 2012. Método: Estudo de agregados de série temporal, cujos dados sobre os óbitos e sobre a população foram obtidos no Sistema de Informação sobre Mortalidade e no Instituto Brasileiro de Geografia e Estatística, respectivamente. Para a análise da tendência temporal, utilizou-se a regressão de Poisson, com a avaliação de superdispersão. Resultados: Observou-se uma redução anual média nas taxas padronizadas de mortalidade por câncer de pâncreas de 0,83% entre os homens e de 0,31% entre as mulheres em Salvador. Já no Estado da Bahia, o aumento foi de 2,40% e de 1,97% entre homens e mulheres, respectivamente. Conclusão: O crescimento das taxas no Estado da Bahia evidencia a importância das ações de prevenção primária direcionadas especialmente para o combate ao tabagismo e ao consumo de álcool, principais fatores de risco associados à incidência dessa neoplasia.

Introduction: The pancreatic cancer presents lethality rates approaching 100%, with about 250,000 annual deaths worldwide. Objective: The aim of this paper is to describe the mortality rate trends of pancreatic cancer in the State of Bahia and Salvador city, from 1980 to 2012. Method: Aggregate study, whose data on deaths and on population were obtained from the Mortality Information System and from the Brazilian Institute of Geography and Statistics, respectively. For the analysis of time trends we used Poisson regression with overdispersion assessment. Results: There was an annual average reduction in standardized mortality rates from pancreatic cancer of 0.83% among men and 0.31% among women in Salvador. In the state of Bahia, the rates increased 2.40% and 1.97% among men and women, respectively. Conclusion: The increasing rates in the State of Bahia, indicating the importance of primary prevention actions against tobacco use and alcohol consumption, the main risk factors associated with the incidence of this neoplasm.

Introducción: El cáncer de páncreas presenta tasas de letalidad que se aproximan al 100%, con cerca de 250.000 muertes anuales en todo el mundo. Objetivo: Describir la tendencia de la tasa de mortalidad por cáncer de páncreas en el Estado de Bahia y en la ciudad de Salvador, entre los años 1980 y 2012. Método: se trata de un estudio de agregados de serie temporal cuyos datos sobre los óbitos y la población han sido obtenidos del Sistema de Información sobre Mortalidad y del Instituto Brasileño de Geografía y Estadística, respectivamente. Para el análisis de la tendencia temporal se ha utilizado la regresión de Poisson, con la evaluación de sobredispersión. Resultados: Se observó una reducción anual media de las tasas estandarizadas de mortalidad por cáncer de páncreas del 0,83% entre los hombres y 0,31% entre las mujeres en Salvador. En el Estado de Bahía, se encontró una tendencia creciente, siendo que ese aumento fue de 2,40% y del 1,97% para los hombres y mujeres, respectivamente. Conclusión: El crecimiento de las tasas indica la importancia de las acciones de prevención primaria dirigidas contra el consumo de tabaco y alcohol, los principales factores de riesgo asociados con la incidencia de esta neoplasia.

Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review / 대한소화기학회지

The prevalence of diabetes mellitus (DM) and associated diseases such as cancers are substantially increasing worldwide. About 80% of the patients with pancreatic cancer have glucose metabolism alterations. This suggests an association between type 2 DM and pancreatic cancer risk and progression. There are hypotheses that show metabolic links between the diseases, due to insulin resistance, hyperglycemia, hyperinsulinemia, low grade chronic inflammation, and alteration in the insulin-insulin-like growth factor axis. The use of diabetes medications can influence the extent of carcinogenesis of the pancreas. This study briefly reviews recent literature on investigation of metabolic link of type 2 DM, risk of carcinogenesis of the pancreas and their association, as well as the current understanding of metabolic pathways implicated in metabolism and cellular growth. The main finding of this review, although there are discrepancies, is that according to most research long-term DM does not raise the risk of pancreatic cancer. The longest duration of DM may reflect hypoinsulinemia due to treatment for hyperglycemia, but recent onset diabetes was associated with increased risk for pancreatic cancer due to hyperinsulinemia and hyperglycemia. In conclusion, the review demonstrates that type 2 DM and the duration of diabetes pose a risk for pancreatic carcinogenesis, and that there is biological link between the diseases.

News Portrayal of Cancer: Content Analysis of Threat and Efficacy by Cancer Type and Comparison with Incidence and Mortality in Korea

How the news media cover cancer may have profound significance for cancer prevention and control; however, little is known about the actual content of cancer news coverage in Korea. This research thus aimed to examine news portrayal of specific cancer types with respect to threat and efficacy, and to investigate whether news portrayal corresponds to actual cancer statistics. A content analysis of 1,138 cancer news stories was conducted, using a representative sample from 23 news outlets (television, newspapers, and other news media) in Korea over a 5-year period from 2008 to 2012. Cancer incidence and mortality rates were obtained from the Korean Statistical Information Service. Results suggest that threat was most prominent in news stories on pancreatic cancer (with 87% of the articles containing threat information with specific details), followed by liver (80%) and lung cancers (70%), and least in stomach cancer (41%). Efficacy information with details was conveyed most often in articles on colorectal (54%), skin (54%), and liver (50%) cancers, and least in thyroid cancer (17%). In terms of discrepancies between news portrayal and actual statistics, the threat of pancreatic and liver cancers was overreported, whereas the threat of stomach and prostate cancers was underreported. Efficacy information regarding cervical and colorectal cancers was overrepresented in the news relative to cancer statistics; efficacy of lung and thyroid cancers was underreported. Findings provide important implications for medical professionals to understand news information about particular cancers as a basis for public (mis)perception, and to communicate effectively about cancer risk with the public and patients.

News Portrayal of Cancer: Content Analysis of Threat and Efficacy by Cancer Type and Comparison with Incidence and Mortality in Korea

How the news media cover cancer may have profound significance for cancer prevention and control; however, little is known about the actual content of cancer news coverage in Korea. This research thus aimed to examine news portrayal of specific cancer types with respect to threat and efficacy, and to investigate whether news portrayal corresponds to actual cancer statistics. A content analysis of 1,138 cancer news stories was conducted, using a representative sample from 23 news outlets (television, newspapers, and other news media) in Korea over a 5-year period from 2008 to 2012. Cancer incidence and mortality rates were obtained from the Korean Statistical Information Service. Results suggest that threat was most prominent in news stories on pancreatic cancer (with 87% of the articles containing threat information with specific details), followed by liver (80%) and lung cancers (70%), and least in stomach cancer (41%). Efficacy information with details was conveyed most often in articles on colorectal (54%), skin (54%), and liver (50%) cancers, and least in thyroid cancer (17%). In terms of discrepancies between news portrayal and actual statistics, the threat of pancreatic and liver cancers was overreported, whereas the threat of stomach and prostate cancers was underreported. Efficacy information regarding cervical and colorectal cancers was overrepresented in the news relative to cancer statistics; efficacy of lung and thyroid cancers was underreported. Findings provide important implications for medical professionals to understand news information about particular cancers as a basis for public (mis)perception, and to communicate effectively about cancer risk with the public and patients.

Entendendo a pesquisa clínica IV: estudos de caso controle / Understanding the clinical research IV: case-control studies

O desenho de um estudo pode ser definido como a forma em que se incluem e comparam os sujeitos da pesquisa com determinadas características. Os estudos são divididos habitualmente em experimentais e não experimentais (observacionais), onde a diferença está na possibilidade do investigador ter ou não controle sobre a exposição de um fator (agente etiológico ou terapêutico). Nos concentraremos aqui no estudo de caso-controle. Um estudo caso-controle é um estudo observacional para determinar se uma exposição está associada com um desfecho. De maneira simplificada, identificar um grupo conhecido por ter o desfecho (casos) e um grupo conhecido por não tê-lo (controles), olhando para trás no tempo para saber quais indivíduos em cada grupo tiveram a exposição e comparar a frequência da exposição no grupo caso com o grupo controle.(AU)

The study design can be defined as the way in which they include and compare the subjects participant with certain characteristics. The studies are usually classified as experimental and non-experimental (observational), whose difference is the possibility of the researcher to control the exposure of a factor (etiological or therapeutic agent). We will focus here on the case-control study. The cohort study is an observational study designed to help determine if an exposure is associated with an outcome. In short words, the case-control study identify a group known to have the outcome (cases) and a group known to be free of the outcome (controls). It looks back in time to learn which subjects in each group had the exposure and compare the frequency of the exposure in the case group to the control group.(AU)

Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions

Cystic neoplasms of the pancreas are found with increasing prevalence, especially in elderly asymptomatic individuals. Although the overall risk of malignancy is very low, the presence of these pancreatic cysts is associated with a large degree of anxiety and further medical investigation due to concerns about malignancy. This review discusses the different cystic neoplasms of the pancreas and reports diagnostic strategies based on clinical features and imaging data. Surgical and nonsurgical management of the most common cystic neoplasms, based on the recently revised Sendai guidelines, is also discussed, with special reference to intraductal papillary mucinous neoplasm (IPMN; particularly the branch duct variant), which is the lesion most frequently identified incidentally. IPMN pathology, its risk for development into pancreatic ductal adenocarcinoma, the pros and cons of current guidelines for management, and the potential role of endoscopic ultrasound in determining cancer risk are discussed. Finally, surgical treatment, strategies for surveillance of pancreatic cysts, and possible future directions are discussed.

Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases

OBJECTIVE: Description of some of the clinical pathological characteristics of neuroendocrine tumors of the gastroenteropancreatic tract in Brazilian patients. INTRODUCTION: Neuroendocrine tumors arise in many organs and share common pathological features. In 2010, the World Health Organization published a new classification for neuroendocrine tumors using a three-tiered system that applies the terms neuroendocrine tumor Grade 1, neuroendocrine tumor Grade 2, and neuroendocrine carcinoma. The tumor grades are based on their mitotic rate and the Ki-67 index. In Brazil, information on neuroendocrine tumors of gastroenteropancreatic tract is scarce. METHODS: This study investigated clinicopathological features of 773 Brazilian gastroenteropancreatic neuroendocrine tumor cases from all the geographic regions of Brazil. All of the cases emerged from the files of a single institution (a large pathology reference laboratory) between 1997 and 2009. In addition, the gastroenteropancreatic neuroendocrine tumors were graded according to the new 2010 World Health Organization classification. RESULTS: Overall there were a higher number of neuroendocrine tumors in female over male. The lower ages were seen in patients with appendiceal tumors. The most common anatomic location involved was stomach followed by small and large intestines. All cases involving the appendix were of grade 1 and 92.1 percent of the neuroendocrine tumors of the esophagus were neuroendocrine carcinomas (grade 3). CONCLUSIONS: In this series, the proportion of NET cases in the total number of surgical pathology cases at our institution over the past 12 years is increasing.